CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 5, 2001, Pages 1249-1257

  Giraud, Philippe ^a,b   Grahek, Dany ^a   Montravers, Françoise ^a   Carette, Marie France ^a   Deniaud Alexandre, Elisabeth ^a   Julia, Frédéric ^a   Rosenwald, Jean Claude ^b   Cosset, Jean Marc ^b   Talbot, Jean Noël ^a   Housset, Martin ^a   Touboul, Emmanuel ^a  

^a HÔPITAL TENON   (France)

^b INSTITUT CURIE   (France)

Author keywords

18F deoxyglucose imaging; Computed tomography; Lung cancer; Three dimensional conformal radiotherapy

Indexed keywords

IRRADIATION; PATIENT TREATMENT; RADIOTHERAPY; SKIN;

LUNG CANCER VOLUMES;

COMPUTERIZED TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FEMALE; HUMAN; IMAGE FUSION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SCINTILLATION CAMERA; TECHNIQUE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR VOLUME; VALIDATION PROCESS;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, RADIOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035312195     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01579-0     Document Type: Conference Paper

References (49)

1. Definition of the prostate in CT and MRI; A multi-observer study
2. Imaging of mediastinal lymph nodes; CT, MR, and FDG PET
3. Positron emission tomography (PET) and [F18]-fluorodeoxyglucose (FDG) in cancerology
4. Bronchogenic carcinoma; Analysis of staging in the mediastinum with CT by correlative lymph node mapping and slamping
5. CT and MRI imaging in staging non-small-cell bronchogenic carcinoma; Report of the radiologic diagnostic oncology group
6. Staging of mediastinal non-small-cell lung cancer with FDG PET, CT, and fusion images; preliminary prospective evaluation
7. Applications of PET in lung cancer
8. PET imaging of primary mediastinal tumours
9. Role of positron emission tomography in the staging of lung cancer
10. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management
11. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer
12. Present results and perspectives of positron emission tomography in oncology and radiotherapy
13. 18F-Deoxyglucose positron emission tomography (FDG-PET)for planning of radiotherapy in lung cancer; High impact in patients with atelectasis
14. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma
15. Glucose transporters and FDG uptake in untreated primary human non-small-cell lung cancer
16. Fluorodeoxyglucose imaging; A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
17. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small-cell lung cancer; A comparative study with X-ray computed tomography
18. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small-cell lung cancer
19. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras
20. Analytical decision model for the cost-effective management of solitary pulmonary nodules
21. Strategy and cost in investigating solitary pulmonary nodules
22. Automatic three-dimensional matching of CT-SPECT and CT-CT to localize lung damage after radiotherapy
23. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose; Comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system
24. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer; comparison with FDG PET
25. Contribution of the FDG scintigraphy on a dual-head coincidence gammacamera (CDET) to the characterisation of pulmonary lesions ans staging of lung cancer
26. Non-small-cell lung cancer; Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
27. Segmentation of lung lesion volume by adaptative positron emission tomography image thresholding
28. Closed-form solution of absolute orientation using unit quaternions
29. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC)
30. Characterization of chest masses by FDG positron emission tomography
31. Positron emission tomography in the pretreatment evaluation and follow- up of non-small-cell lung cancer patients treated with radiotherapy; Preliminary findings
32. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma
33. Impact of PET scan on the target volume in lung cancer radiotherapy planning
34. Integration of multimodality imaging data for radiotherapy treatment planning
35. Chemotherapy effect on locally advanced non small cell lung carcinoma; A randomized study of 353 patients
36. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer
37. The use of active breathing control (ABC) to reduce margin for breathing motion
38. Differential diagnosis of lung tumor with positron emission tomography; A prospective study
39. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging
40. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET
41. Pulmonary abnormalities and PET data analysis; A restrospective study
42. Selective use of PET scan in the preoperative staging of NSCLC
43. Likelihood of malignancy in a solitary pulmonary nodule; Comparison of Bayesian analysis and results of FDG-PET scan
44. Prospective investigation of positron emission tomography in lung nodules
45. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]-fluorodeoxyglucose
46. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small-cell lung cancer; A prospective analysis of 50 cases. Leuven Lung Cancer Group
47. Lymph node staging in non-small-cell lung cancer; Evaluation by [18F]FDG positron emission tomography (PET)
48. Lymph node staging in non-small-cell lung cancer with FDG-PET scan; A prospective study on 690 lymph node stations from 68 patients
49. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma